1. Home
  2. FOSL vs MNPR Comparison

FOSL vs MNPR Comparison

Compare FOSL & MNPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FOSL
  • MNPR
  • Stock Information
  • Founded
  • FOSL 1984
  • MNPR 2014
  • Country
  • FOSL United States
  • MNPR United States
  • Employees
  • FOSL N/A
  • MNPR N/A
  • Industry
  • FOSL Consumer Specialties
  • MNPR Biotechnology: Pharmaceutical Preparations
  • Sector
  • FOSL Consumer Discretionary
  • MNPR Health Care
  • Exchange
  • FOSL Nasdaq
  • MNPR Nasdaq
  • Market Cap
  • FOSL 100.0M
  • MNPR 113.5M
  • IPO Year
  • FOSL 1993
  • MNPR 2019
  • Fundamental
  • Price
  • FOSL $1.76
  • MNPR $31.68
  • Analyst Decision
  • FOSL
  • MNPR Strong Buy
  • Analyst Count
  • FOSL 0
  • MNPR 4
  • Target Price
  • FOSL N/A
  • MNPR $38.50
  • AVG Volume (30 Days)
  • FOSL 522.1K
  • MNPR 57.5K
  • Earning Date
  • FOSL 03-12-2025
  • MNPR 11-08-2024
  • Dividend Yield
  • FOSL N/A
  • MNPR N/A
  • EPS Growth
  • FOSL N/A
  • MNPR N/A
  • EPS
  • FOSL N/A
  • MNPR N/A
  • Revenue
  • FOSL $1,223,954,000.00
  • MNPR N/A
  • Revenue This Year
  • FOSL N/A
  • MNPR N/A
  • Revenue Next Year
  • FOSL N/A
  • MNPR N/A
  • P/E Ratio
  • FOSL N/A
  • MNPR N/A
  • Revenue Growth
  • FOSL N/A
  • MNPR N/A
  • 52 Week Low
  • FOSL $0.75
  • MNPR $1.55
  • 52 Week High
  • FOSL $2.61
  • MNPR $38.50
  • Technical
  • Relative Strength Index (RSI)
  • FOSL 49.72
  • MNPR 65.69
  • Support Level
  • FOSL $1.61
  • MNPR $24.00
  • Resistance Level
  • FOSL $1.97
  • MNPR $26.52
  • Average True Range (ATR)
  • FOSL 0.16
  • MNPR 2.61
  • MACD
  • FOSL -0.02
  • MNPR 0.52
  • Stochastic Oscillator
  • FOSL 35.71
  • MNPR 92.67

About FOSL Fossil Group Inc.

Fossil Group Inc is a design, innovation and distribution company in consumer fashion accessories. The products include traditional watches, smartwatches, jewelry, handbags, small leather goods, belts and sunglasses. The reportable segments are comprised of 1) Americas segment includes sales in Canada, Latin America and the United States. 2) Europe segment includes sales in European countries, the Middle East and Africa. 3) Asia segment includes sales in Australia, China, India, Indonesia, Japan, Malaysia, New Zealand, Singapore, South Korea and Thailand. Each reportable operating segment includes sales to wholesale and distributor customers, and sales through Company-owned retail stores and e-commerce activities based on the location of the selling entity.

About MNPR Monopar Therapeutics Inc.

Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicin for the treatment of soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.

Share on Social Networks: